Thomas E. Keim, Jr.

Thomas “Ted” Keim, Jr. is a member of Latham & Watkins’ Strategic Client Initiative and the Finance Committee, and is the former Chair of the Chicago Corporate Department.

Mr. Keim’s practice focuses primarily on mergers and acquisitions, both in the US and globally, for a broad range of public and private clients. Mr. Keim’s practice reflects a wide range of transactional experience, including mergers and acquisitions, divestitures, private equity, investment and venture capital transactions, joint ventures, corporate reorganizations and restructurings, and company representation matters.

Mr. Keim regularly represents companies across a broad spectrum of industries, including clients in retail, lodging/hospitality, pharmaceuticals, life sciences/biotech, aerospace and defense, bioenergy and industrials.

In Chambers USA 2014, observers praised Mr. Keim as "incredible, spectacular [and] possessing a lucid and reassuring personal style."

Mr. Keim is a member of the Auxiliary Board of The Art Institute of Chicago and the Associate Board of the Rehabilitation Institute of Chicago.

Mr. Keim’s recent transactions include:

Baxter/Baxalta in acquisition of Oncaspar portfolio from Sigma-Tau Pharmaceuticals (2015, pending)
Carlyle Group and PAI Partners in the US$900 million control acquisition of the Custom Sensors & Technologies business of Schneider Electric S.A. (2014)
Safeway Inc. in the CDN$5.8 billion sale of its Canadian grocery operations to Sobeys Inc. (2013-2014)
Vitamin Shoppe Inc. in its US$50 million acquisition of Super Supplements Inc. (2013)
Koch Industries/Flint Hills Resources in various bioenergy/ethanol plant acquisitions (2012-2013)
Pritzker family business interests and Madison Dearborn Partners in the US$3.2 billion sale of TransUnion Corp. to Advent International and Goldman Sachs Capital Partners (2012)
J.L. French Automotive Castings, a high-pressure die casting aluminum auto parts manufacturer, in its sale to Nemak/Alfa (2012)
Walgreen Co. in its acquisition of Crescent Healthcare, Inc., an infusion pharmacy company (2012)
Wrightwood Capital in the sale of its investment platform to Ares Commercial Real Estate (2011)
Marmon Holdings, Inc. and the Pritzker Family Business interests in the more than US$8 billion staged sale of Marmon Holdings to Berkshire Hathaway (2008-2013)
Integra LifeSciences Holdings Corporation in its US$200 million acquisition of Theken Spine and related companies (2008)
Reliant Pharmaceuticals, Inc., a specialty pharmaceutical company, in its US$1.7 billion sale to GlaxoSmithKline (2007)